Status:
COMPLETED
Text Messaging to Improve Adherence to Oral Chemotherapy Agents
Lead Sponsor:
Michigan State University
Collaborating Sponsors:
Yale University
Sparrow Health System
Conditions:
Cancer
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The purpose of this Academic Research Enhancement Award proposal is to conduct a small-scale health-related research project on text messages to improve adherence to oral chemotherapy agents. Michigan...
Detailed Description
The therapeutic outcome of cancer treatment for patients taking oral chemotherapy agents depends heavily on adherence to the oral agent regimen. Yet recent research indicated that patients miss one-th...
Eligibility Criteria
Inclusion
- Diagnosed with cancer
- Prescribed an oncolytic or therapeutic oral agent (non-hormonal)
- Able to speak, read, and understand English
- Able and willing to receive phone calls
- Has a personal cell phone, and able and willing to receive and send a text message
Exclusion
- Deaf, blind, or unable hear, or unable to accept phone calls
- Prescribed hormonal therapy for cancer treatment
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT01889511
Start Date
June 1 2013
End Date
June 1 2015
Last Update
September 21 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
New Haven, Connecticut, United States, 06520-8034
2
Diplomat Specialty Pharmacy
Flint, Michigan, United States, 48507
3
McLaren Cancer Institute
Flint, Michigan, United States, 48532
4
Allegiance Health
Jackson, Michigan, United States, 49201